X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Dishman Pharma with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs UNICHEM LAB - Comparison Results

DISHMAN PHARMA    Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA UNICHEM LAB DISHMAN PHARMA/
UNICHEM LAB
 
P/E (TTM) x 25.1 22.2 113.2% View Chart
P/BV x 3.3 2.3 143.4% View Chart
Dividend Yield % 0.7 0.8 81.6%  

Financials

 DISHMAN PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
UNICHEM LAB
Mar-16
DISHMAN PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs374334 112.1%   
Low Rs129174 74.1%   
Sales per share (Unadj.) Rs197.8146.9 134.6%  
Earnings per share (Unadj.) Rs21.211.9 178.3%  
Cash flow per share (Unadj.) Rs34.716.2 214.5%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.80.8 100.9%  
Book value per share (Unadj.) Rs179.9105.1 171.1%  
Shares outstanding (eoy) m80.6990.84 88.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.31.7 73.6%   
Avg P/E ratio x11.921.4 55.6%  
P/CF ratio (eoy) x7.215.7 46.2%  
Price / Book Value ratio x1.42.4 57.9%  
Dividend payout %9.416.8 56.1%   
Avg Mkt Cap Rs m20,30623,073 88.0%   
No. of employees `0000.85.7 14.6%   
Total wages/salary Rs m5,3552,558 209.3%   
Avg. sales/employee Rs Th19,252.72,352.5 818.4%   
Avg. wages/employee Rs Th6,459.5450.9 1,432.6%   
Avg. net profit/employee Rs Th2,064.1190.4 1,083.8%   
INCOME DATA
Net Sales Rs m15,96113,346 119.6%  
Other income Rs m265192 138.3%   
Total revenues Rs m16,22613,538 119.9%   
Gross profit Rs m4,1031,639 250.3%  
Depreciation Rs m1,091390 279.6%   
Interest Rs m94429 3,279.2%   
Profit before tax Rs m2,3341,412 165.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m1-4 -29.7%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m624293 213.1%   
Profit after tax Rs m1,7111,080 158.4%  
Gross profit margin %25.712.3 209.3%  
Effective tax rate %26.720.7 128.9%   
Net profit margin %10.78.1 132.4%  
BALANCE SHEET DATA
Current assets Rs m11,0185,979 184.3%   
Current liabilities Rs m9,5172,432 391.3%   
Net working cap to sales %9.426.6 35.4%  
Current ratio x1.22.5 47.1%  
Inventory Days Days11063 175.2%  
Debtors Days Days3560 57.7%  
Net fixed assets Rs m16,3046,403 254.6%   
Share capital Rs m161182 88.8%   
"Free" reserves Rs m12,9079,293 138.9%   
Net worth Rs m14,5169,548 152.0%   
Long term debt Rs m4,189230 1,818.3%   
Total assets Rs m29,80512,843 232.1%  
Interest coverage x3.550.0 6.9%   
Debt to equity ratio x0.30 1,196.1%  
Sales to assets ratio x0.51.0 51.5%   
Return on assets %8.98.6 103.2%  
Return on equity %11.811.3 104.2%  
Return on capital %17.514.3 122.3%  
Exports to sales %24.829.2 84.8%   
Imports to sales %3.76.3 58.9%   
Exports (fob) Rs m3,9563,900 101.5%   
Imports (cif) Rs m596847 70.4%   
Fx inflow Rs m4,9524,356 113.7%   
Fx outflow Rs m6971,162 60.0%   
Net fx Rs m4,2553,194 133.2%   
CASH FLOW
From Operations Rs m2,7861,119 249.0%  
From Investments Rs m-1,529-853 179.2%  
From Financial Activity Rs m-941-334 281.6%  
Net Cashflow Rs m316-68 -463.3%  

Share Holding

Indian Promoters % 61.4 50.1 122.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 15.1 24.5%  
FIIs % 12.7 3.0 423.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.1 31.7 69.7%  
Shareholders   46,261 20,176 229.3%  
Pledged promoter(s) holding % 35.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   PANACEA BIOTECH  BIOCON LTD  J.B.CHEMICALS  NATCO PHARMA  AJANTA PHARMA  

Compare DISHMAN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 200 Points Higher; Lupin & Axis Bank Top Gainers(09:30 am)

Majority of Asian stock indices are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.07%, while the Hang Seng is up 1.06%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA - ALKEM LABORATORIES COMPARISON

COMPARE DISHMAN PHARMA WITH

MARKET STATS